Metformin's effects beyond ischemia: Evaluating cardioprotection in nonischemic myocardium in a large animal model of coronary and metabolic disease
Abstract
Objective: This study evaluated the effects of metformin (MET) on nonischemic myocardium in a large animal model of coronary artery disease and metabolic syndrome (MS). Although prior work has shown MET improves perfusion and function in ischemic tissue, this study assessed whether its cardioprotective effects extend to nonischemic regions. Methods: Yorkshire swine (n = 12) were fed a high-fat diet to induce MS and then underwent ameroid constrictor placement around the left circumflex artery to simulate coronary artery disease. Animals received either oral MET (1000 mg/day) or placebo for 7 weeks. Regional myocardial perfusion was assessed via microsphere injections at rest and during pacing. Nonischemic myocardial tissue was identified using gold microsphere distribution and analyzed using immunoblotting, immunofluorescence, and hemodynamic assessment. Statistical significance was evaluated using Student t test or the Mann Whitney U test. Results: Despite no significant changes in perfusion, MET-treated animals demonstrated significantly reduced apoptotic markers (caspase 9, cleaved caspase 9, apoptosis-inducing factor, and Bcl2-associated agonist of cell death (BAD); P < .05) and increased phosphorylated BAD/BAD ratios. Prosurvival signaling was enhanced with elevated phosphorylated protein kinase B (AKT)/AKT, phosphorykated mammalian target of rapamycin (mTOR)/mTOR, and phosphorylated AMP-activated protein kinase (AMPK)/AMPK ratios (P < .05). Tansferase dUTP nick end…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.